English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Lundbeck
Carol Ostrow
| Jan 12, 2018
Lundbeck teams up with Vanderbilt on schizophrenia treatment
Robert Hadley
| Mar 30, 2017
Europe to evaluate antipsychotic drug for approval
Amanda Rupp
| Aug 8, 2016
FDA gives idalopirdine Fast Track Designation
Jamie Barrand
| Feb 10, 2016
Manufacturers hope to expand labeling on schizophrenia therapy
Wendell Hutson
| Sep 20, 2015
Brintellix gets drug approval by FDA
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
